Rapid Developments in Pharmaceutical and Biotechnology Research is Fueling Middle East & Africa
Biosafety Cabinet Market
R&D is a significant and essential part of the business of pharmaceuticals and biopharmaceutical companies. R&D enables companies to come up with new medicines for various therapeutic applications with significant medical and commercial potential. There has been an increase in R&D spending by biopharmaceutical companies over the years. Drug development and discovery are time-consuming and expensive processes. These processes involve various stages, including early detection of a target, designing of a molecule, and development and regulatory approval. The entire process can take more than 10-15 years. Throughout the drug development phase, various testing services are required to check the quality and efficacy of the drug. In the development and modification of a new vaccine strain for infectious disease, various cell culture studies and experiments are performed that majorly requires biosafety cabinets. Furthermore, increasing demand for smart laboratories has led to the development of smart biosafety cabinets with cloud-based, Internet of Things (IoT), and Artificial Intelligence (AI) technologies. Thus, the rising number of molecules entering clinical trial studies and ramp-up in R&D, along with the growing trend of smart laboratories, will create ample opportunities for the Middle East & Africa biosafety cabinet market during the forecast period.Middle East & Africa Biosafety Cabinet Market Overview
The Middle East & Africa biosafety cabinet market is segmented into South Africa, Nigeria, Kenya, Saudi Arabia, the UAE, Kuwait, Egypt, the Rest of Middle East, and the Rest of Africa. Saudi Arabia is expected to account for the largest market share and is expected to develop moderately in the Middle East during the forecast period. The market growth is attributed to various factors such as extensive research projects undertaken by research institutes and availability of infrastructure and facilities for research in the UAE and Saudi Arabia. In Africa, only Kenya, Nigeria, and South Africa have a relatively sizable industry, with dozens of companies that produce for their local markets and, in some cases, for export to neighboring countries. Local producers also play in a limited range of the value chain. Local manufacturers often have the incentives and resources to introduce newer generation generics into Africa promoting the biosafety cabinet market.Exhibit: Middle East & Africa Biosafety Cabinet Market Revenue and Forecast to 2028 (US$ Million)
Middle East & Africa Biosafety Cabinet Market Segmentation
The Middle East & Africa biosafety cabinet market is segmented into products handled, category, type, application, end user, and country.Based on products handled, the Middle East & Africa biosafety cabinet market is bifurcated into biological products and toxic products. The biological products segment held a larger share of the Middle East & Africa biosafety cabinet market in 2023.
Based on category, the Middle East & Africa biosafety cabinet market is segmented into work trays, side panel construction, and accessories. The work trays segment held the largest share of the Middle East & Africa biosafety cabinet market in 2023.
Based on type, the Middle East & Africa biosafety cabinet market is segmented into class I biosafety cabinet, class II type A2 & class II type B1, class II type B2 biosafety cabinet, class II biosafety cabinet, customized cabinets, and others. The class II type A2 & class II type B1 segment held the largest share of the Middle East & Africa biosafety cabinet market in 2023.
Based on application, the Middle East & Africa biosafety cabinet market is segmented into medical health, disease prevention, food safety, biological pharmacy, environment monitoring, and others. The disease prevention segment held the largest share of the Middle East & Africa biosafety cabinet market in 2023.
Based on end user, the Middle East & Africa biosafety cabinet market is segmented into academic centers, biotech & pharmaceutical companies, microbiology centers, research & development centers, hospitals & clinics, diagnostic laboratories, and others. The biotech & pharmaceutical companies segment held the largest share of the Middle East & Africa biosafety cabinet market in 2023.
Based on country, the Middle East & Africa biosafety cabinet market has been categorized into South Africa, Nigeria, Kenya, Saudi Arabia, the UAE, Kuwait, Egypt, the Rest of Middle East, and the Rest of Africa. Our regional analysis states that Saudi Arabia dominated the Middle East & Africa biosafety cabinet market in 2023.
ACMAS Technologies, Biobase Biodusty Co Ltd, Esco Group of Companies, Haier Biomedical, Kewaunee Scientific Corp, Labconco Corp, NuAire Inc, and Thermo Fisher Scientific Inc are the leading companies operating in the Middle East & Africa biosafety cabinet market.
Table of Contents
Companies Mentioned
- ACMAS Technologies
- Biobase Biodusty Co Ltd
- Esco Group of Companies
- Haier Biomedical
- Kewaunee Scientific Corp
- Labconco Corp
- NuAire Inc
- Thermo Fisher Scientific Inc
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 145 |
Published | July 2023 |
Forecast Period | 2023 - 2028 |
Estimated Market Value ( USD | $ 10.57 million |
Forecasted Market Value ( USD | $ 13.96 million |
Compound Annual Growth Rate | 5.7% |
Regions Covered | Africa, Middle East |
No. of Companies Mentioned | 8 |